LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.
CEO: |
Paul Carmelo Pagano |
Non-Executive Director: |
Sara Barrington |
Non-Executive Chairman: |
Gordon Roy Davis |
Senior Independent Non-Executive Director: |
Andrew Norman Boteler |
Chief Finance Officer: |
David Mark Anderson |
Address: |
850 New Burton Road, Suite 201, Dover, Delaware, USA |
Phone: |
|
Fax: |
|
Website: |
https://www.lunglifeai.com/ |
Email: |
|